Taiho Oncology, Inc.
Sheryl Salidas Knepp is a seasoned professional in quality operations and compliance, currently serving as Senior Director of Quality Operations at Taiho Oncology, Inc. since July 2023. With over 14 years of experience at Janssen Inc., Sheryl held various roles, including Director of Compliance and Data Integrity, where Sheryl was instrumental in enhancing quality standards and ensuring compliance throughout drug development processes. Sheryl also served as Associate Director and Senior Compliance Manager at Janssen Biotherapeutics, focusing on integrating quality into operations and leading global teams to uphold regulatory compliance. Beginning her career as a Compliance Analyst and Quality Control Analyst at Centocor, Inc., Sheryl has a strong foundation in quality assurance and regulatory practices. Sheryl holds a Master’s degree in Clinical Pharmacology from Thomas Jefferson University and a B.S. in Biology from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com